Search
for
Sort by
Research 721–750 of 1000+
- Functional analysis of the stratum corneum of scalp skin: studies in patients with alopecia areata and androgenetic alopecia
- Selected Disorders of Skin Appendages—Acne, Alopecia, Hyperhidrosis
- Coat condition, housing condition and measurement of faecal cortisol metabolites - a non-invasive study about alopecia in captive rhesus macaques (Macaca mulatta)
- EEMCO Guidance for the Assessment of Hair Shedding and Alopecia
- Element concentrations in serum, erythrocytes, hair and urine of alopecia patients
- Immune Privilege Collapse and Alopecia Development: Is Stress a Factor
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Diagnosis and Management of Alopecia in Children
- Successful Treatment of Alopecia Areata with Topical Calcipotriol
- Advances in the management of alopecia areata
- Hereditary 1,25-dihydroxyvitamin D-resistant rickets with alopecia resulting from a novel missense mutation in the DNA-binding domain of the vitamin D receptor
- Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3 in a patient without alopecia
- A systematic review of pulse steroid therapy for alopecia areata
- Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study
- Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis
- Topical Treatment of Alopecia Areata
- Alopecia secondary to mesotherapy
- Post-menopausal frontal fibrosing alopecia
- Optimal Management of Hair Loss (Alopecia) in Children
- Minoxidil (Mx) as a prophylaxis of doxorubicin – induced alopecia
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab
- Drug-induced alopecia after dupilumab therapy
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Clobetasol Propionate, 0.05%, vs Hydrocortisone, 1%, for Alopecia Areata in Children
- Alopecia areata update
- Alopecia Areata